Disclosed is an isolated antibody or antigen-binding portion thereof, directed against a target CD40 polypeptide, wherein said antibody or antigen-binding portion comprises the heavy and light chains of the sequences as defined in the specification. Also disclosed is the use of the antibody to treat an autoimmune or inflammatory disorder.